The global excipients market size was estimated at USD 10.69 billion in 2025 and is projected to reach USD 14.74 billion by 2033, growing at a CAGR of 4.11% from 2026 to 2033. Excipients are increasingly valued for enhancing drug functionality and offering a competitive edge in formulations, driving their widespread adoption among pharmaceutical companies.
Continuous research and development of optimized excipients for improved drug delivery have strengthened market growth, while the trend toward more advanced, multifunctional excipients is shaping the current pharmaceutical landscape. Excipients continue to play a critical role in enhancing drug functionality and improving patient outcomes, driving widespread adoption among pharmaceutical companies. Rising demand for advanced excipients that support nanoparticle drug delivery and targeted therapies in oncology, metabolic, and chronic disease treatments is boosting innovation and adoption. Patent expirations of major drugs are also encouraging the development of optimized formulations with multifunctional excipients to improve stability, solubility, and bioavailability.
Pharmaceutical firms are now actively engaged in R&D for next-generation excipients, focusing on compatibility with biologics, sustained-release formulations, and patient-friendly delivery systems. For instance, in December 2025, Pfizer Inc. and Cipla Ltd. entered a strategic partnership in India under which Cipla will exclusively market and distribute four key Pfizer brands across the country, combining Pfizer’s established products with Cipla’s extensive distribution network to expand access to essential medications nationwide, highlighting the role of collaborations in advancing drug formulation and delivery innovation.
The growing emphasis on customized drug delivery is further driving excipient innovation, as companies aim to improve bioavailability and patient compliance. Firms like Novartis AG, Sanofi S.A., and Teva Pharmaceutical Industries Ltd. are exploring multifunctional excipients for oral, injectable, and sustained-release formulations. Increasing collaborations between pharmaceutical and specialty chemical companies are accelerating the development of stable, high-performance excipients suitable for complex therapies. In addition, the integration of excipients in nanoparticle and biologic formulations is expanding their role in targeted treatment strategies. Regulatory agencies are also encouraging the adoption of advanced excipients through updated guidelines, ensuring safety and quality. Together, these trends are expected to sustain robust growth and innovation in the excipients sector over the coming years.
Continuous research and development of optimized excipients for improved drug delivery have strengthened market growth, while the trend toward more advanced, multifunctional excipients is shaping the current pharmaceutical landscape. Excipients continue to play a critical role in enhancing drug functionality and improving patient outcomes, driving widespread adoption among pharmaceutical companies. Rising demand for advanced excipients that support nanoparticle drug delivery and targeted therapies in oncology, metabolic, and chronic disease treatments is boosting innovation and adoption. Patent expirations of major drugs are also encouraging the development of optimized formulations with multifunctional excipients to improve stability, solubility, and bioavailability.
Pharmaceutical firms are now actively engaged in R&D for next-generation excipients, focusing on compatibility with biologics, sustained-release formulations, and patient-friendly delivery systems. For instance, in December 2025, Pfizer Inc. and Cipla Ltd. entered a strategic partnership in India under which Cipla will exclusively market and distribute four key Pfizer brands across the country, combining Pfizer’s established products with Cipla’s extensive distribution network to expand access to essential medications nationwide, highlighting the role of collaborations in advancing drug formulation and delivery innovation.
The growing emphasis on customized drug delivery is further driving excipient innovation, as companies aim to improve bioavailability and patient compliance. Firms like Novartis AG, Sanofi S.A., and Teva Pharmaceutical Industries Ltd. are exploring multifunctional excipients for oral, injectable, and sustained-release formulations. Increasing collaborations between pharmaceutical and specialty chemical companies are accelerating the development of stable, high-performance excipients suitable for complex therapies. In addition, the integration of excipients in nanoparticle and biologic formulations is expanding their role in targeted treatment strategies. Regulatory agencies are also encouraging the adoption of advanced excipients through updated guidelines, ensuring safety and quality. Together, these trends are expected to sustain robust growth and innovation in the excipients sector over the coming years.
Global Excipients Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global excipients market report based on product, formulation, function, and region:Product Outlook (Revenue, USD Million, 2021-2033)
- Polymers
- MCC
- HPMC
- Ethyl Cellulose
- Methyl Cellulose
- CMC
- Croscarmellose Sodium
- Povidone
- Pregelatinized starch
- Sodium starch glycolate
- Polyethylene Glycol
- Acrylic Polymers
- Alcohols
- Glycerin
- Propylene Glycol
- Sorbitol
- Mannitol
- Others
- Sugar
- Lactose
- Sucrose
- Others
- Minerals
- Calcium Phosphate
- Calcium Carbonate
- Clay
- Silicon Dioxide
- Titanium Dioxide
- Others
- Gelatin
Formulation Outlook (Revenue, USD Million, 2021-2033)
- Oral
- Topical
- Parenteral
- Others
Function Outlook (Revenue, USD Million, 2021-2033)
- Fillers and Diluents
- Suspending & Viscosity Agents
- Coating Agents
- Binders
- Flavoring Agents & Sweeteners
- Disintegrants
- Colorants
- Lubricants and Glidants
- Preservatives
- Emulsifying Agents
- Others
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Excipients Market Variables, Trends, & Scope
Chapter 4. Excipients Market: Product Business Analysis
Chapter 5. Excipients Market: Formulation Business Analysis
Chapter 6. Excipients Market: Function Business Analysis
Chapter 7. Excipients Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Eastman Chemical Corporation
- P&G Chemicals
- Avantor Performance Materials, LLC
- Huntsman Corporation
- BASF SE
- Ashland Inc.
- FMC Corporation
- Roquette
- Colorcon Inc.
- Lubrizol Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 10.69 Billion |
| Forecasted Market Value ( USD | $ 14.74 Billion |
| Compound Annual Growth Rate | 4.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
